Justin Field, MD
Orthopaedic Surgery of the Spine · Phoenix, AZNPI 1770524324
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (48.5%), other and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Globus Medical at 45.9% of the total. Reporting peaked in 2021 at $490,052 and has fallen 74.8% since, to $123,709 in 2025. Among orthopaedic surgery of the spine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $5917.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$1M
- Omnia Medical, LLC$830K
- Stryker$176K
- L&k Spine Inc$111K
- Surgalign Spine Technologies, Inc.$29K
- Precision Spine, Inc.$27K
- plus $60K from 27 others
Across 14 payments — averaging $20,239 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Spineart SA$280K
- Intrinsic Therapeutics$3K
Across 5 payments — averaging $18,070 each. An ownership or investment interest held by the physician or an immediate family member.
- Amplify Surgical, Inc.$90K
What the payments were for
- Royalty or licence$1,105,59649%
- Consulting fees$258,22011%
- Speaking & faculty fees$175,9308%
- Travel & lodging$4,4830%
- Food & beverage$14,1241%
- Other$720,00032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 88 | $1,045,115 |
| Omnia Medical, LLC | 8 | $830,000 |
| Stryker | 4 | $176,016 |
| L&k Spine Inc | 2 | $111,300 |
| Surgalign Spine Technologies, Inc. | 15 | $29,495 |
| Precision Spine, Inc. | 8 | $26,607 |
| Xtant Medical Inc | 8 | $14,115 |
| Corelink, LLC | 17 | $10,357 |
| Nexxt Spine LLC | 12 | $9,420 |
| Spinal Simplicity, LLC | 6 | $7,875 |
| Spine Wave, Inc. | 70 | $3,769 |
| Abbott | 35 | $3,725 |
| Intrinsic Therapeutics | 29 | $3,673 |
| Zavation Medical Products, LLC | 19 | $2,767 |
| Zimmer Biomet | 2 | $1,050 |
| Spineart USA Inc | 6 | $796 |
| Boston Scientific | 9 | $781 |
| Nevro Corp. | 10 | $381 |
| Surgentec | 1 | $156 |
| Radius Health, Inc. | 7 | $139 |
| Biotronik NRO, Inc. | 1 | $125 |
| Pfizer | 6 | $119 |
| Spineology Inc. | 3 | $102 |
| Medtronic(2 entities) | 3 | $82 |
| Novo Nordisk | 3 | $64 |
| Painteq LLC | 1 | $60 |
| Providence Medical Technology, Inc. | 3 | $59 |
| Johnson & Johnson(2 entities) | 3 | $51 |
| Centinel Spine, LLC | 1 | $47 |
| Baxter Healthcare | 2 | $43 |
| Theragen, Inc. | 1 | $25 |
| Vertex | 1 | $25 |
| Forte Bio-pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RISE$912,249
- MAGNIFY$109,621
- Vault C$26,607
- CervAlign Anterior Cervical Plate$17,031
- CERVALIGN ANTERIOR CERVICAL PLATE SYSTEM$12,412
- Magnify-S / Magnify$12,264
- SI System$7,725
- MAGNIFY-S$7,466
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$6,359
- LIBERTY SI$5,713
- HA MINUTEMAN G3-R$2,162
- Affix$1,928
- PROCLAIM$1,412
- Nexxt Matrixx SI$1,170
- PD-Spine-New Product$600
- PrimaGen$600
- Proclaim Family of SCS IPGs$515
- Proclaim IPG$514
- Vitality$450
- Vital$450
How this compares
$2,278,353 in reported general payments places this provider in the 95th percentile of 64 orthopaedic surgery of the spine providers in Arizona.
See all orthopaedic surgery of the spine providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 65 | $722 |
| Cyclobenzaprine Hcl | 44 | $448 |
| Methylprednisolone | 58 | $313 |
| Tramadol Hcl | 14 | $72 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Phoenix
- Nima SalariPhoenix$741K
- Harvinder BediPhoenix$740K
- Mark WangPhoenix$573K
- Joshua AbramsPhoenix$311K
- Louis RappoportPhoenix$236K
- David JacksonPhoenix$189K
- Kunwar KhalsaPhoenix$182K
- Norman ChutkanPhoenix$114K
- Shaleen ViraPhoenix$109K
- Vikram MayuranPhoenix$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.